| __timestamp | Amphastar Pharmaceuticals, Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 4534000000 |
| Thursday, January 1, 2015 | 37065000 | 5920000000 |
| Friday, January 1, 2016 | 41199000 | 4940000000 |
| Sunday, January 1, 2017 | 43415000 | 6411000000 |
| Monday, January 1, 2018 | 57564000 | 6345000000 |
| Tuesday, January 1, 2019 | 68853000 | 6148000000 |
| Wednesday, January 1, 2020 | 67229000 | 11143000000 |
| Friday, January 1, 2021 | 60932000 | 10195000000 |
| Saturday, January 1, 2022 | 74771000 | 9509000000 |
| Sunday, January 1, 2023 | 73741000 | 9299000000 |
| Monday, January 1, 2024 | 11159000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. From 2014 to 2023, Bristol-Myers Squibb Company and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. Bristol-Myers Squibb, a global biopharmaceutical giant, consistently allocated a significant portion of its resources to R&D, peaking in 2020 with a staggering 11% increase from the previous year. This strategic focus underscores their dedication to pioneering new treatments and maintaining a competitive edge. In contrast, Amphastar Pharmaceuticals, a smaller player, showed a steady yet modest increase in R&D spending, with a notable 26% rise from 2014 to 2023. This growth reflects their strategic intent to enhance their product pipeline and expand their market presence. The data highlights the diverse approaches these companies take in navigating the ever-evolving pharmaceutical industry.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds